In the Spotlight
Watch out—momentum stocks are out of favor
Crispr Therapeutics AG: “Here’s the problem: that’s a momentum stock, and right now, momentum is out of favor so I cannot necessarily recommend that Crispr is the place to be.” Camping World Holdings: “I think [...]
-
The first quarter has been a banner period for Wall Street. The S&P 500 is up more than 12 percent this quarter and is on [...]
